Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Avego Bioscience Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Average round size
info
The average size of a deal this fund participated in
$115M
Portfolio companies 1
Lead investments 0
Key employees Soon

Areas of investment

  • Therapeutics
  • Health Care
  • Biotechnology

Look at other 50 related and similar funds Collapse list
Fund NameLocation
BeyondTrust California, Carlsbad, United States
Dongfang Weixin Keji China, Tianjin, Tianjin
Hicks Oilfield -
Integrated Networks Ar Riyad, Riyadh, Saudi Arabia
JMCR Partners China, Hong Kong, Hong Kong Island
Johnsonville Sausage United States, Watertown, Wisconsin
KKR & Co. New York, New York, United States
Klever Internet Moscow, Moscow, Russia
Local Initiatives Support Corporation New York, New York, United States
Magma Fincorp India, Kolkata, West Bengal
Oppenheim Pramerica Asset Management Luxembourg, Luxembourg
Piper Jaffray Minneapolis, Minnesota, United States
Revelis Capital Group Colorado, Denver, United States
Sanden Gunma Prefecture, Isesaki, Japan
Shanghai Yijinghui Asset Management China, Shanghai
StartVenture California, San Francisco, United States
Suzhou Xiangtang Venture Capital China, Jiangsu, Suzhou
Wanjia Gongying Zichan Guanli China, Shanghai
Zhong Zao Weilai Beijing, Beijing, China
Zhongqihui Venture Capital China, Guangdong, Shenzhen

News
Ribon Therapeutics Secures $65 Million Financing

– Ribon Therapeutics announced the closing of a $65m financing.
– The financing was led by Deerfield Management and U.S. Venture Partners, with support from new investors Avego BioScience Capital, GV (formerly Google Ventures), Monashee Investment Management and Peregrine Ventures, along with existing investors AbbVie Ventures, Bristol Myers Squibb, Euclidean Capital, Johnson & Johnson Innovation, Novartis Venture Fund, Osage University Partners, Takeda Ventures and The Column Group.
– Ribon will use the proceeds to support the clinical development of its novel precision medicine candidates.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Avego Bioscience Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: